Investor Relations
Disclosures under Regulation 46 of the SEBI (LODR) Regulations, 2015.
Board of Directors
Board & Board Committees
| Name | Designation | Audit Committee | Risk Management Committee | Nomination & Remuneration Committee | Stakeholders Relationship Committee | CSR & ESG Committee | Treasury Management Committee |
|---|---|---|---|---|---|---|---|
| Mr. Aluri Srinivasa Rao | Independent Director | 
|
|
|
|
- | - |
| Dr. Anil Dhawan | Independent Director |
|
- |
|
|
|
- |
| Mr. Santanu Mukherjee | Independent Director |
|
|
|
- |
|
|
| Ms. Sundari R. Pisupati | Independent Director |
|
- |
|
|
|
- |
| Dr. Ramesh Kancharla | Chairman & Managing Director | - |
|
- |
|
|
|
| Dr. Dinesh Kumar Chirla | Whole-Time Director | - | - | - | - |
|
- |
| Dr. Adarsh Kancharla | Non-Executive Director | - |
|
- | - |
|
- |
| Mr. Vikas Maheshwari | Group Chief Financial Officer (KMP) | - |
|
- | - | - |
|
Chairperson
Member
Policies & Programs
- Policy on determination of materiality for disclosure of events or information
- Familiarisation Programme for Independent Directors for FY 2023-24
- CSR Projects approved by the Board for FY 2023-24
- Familiarisation Programme for Independent Directors for FY 2022-23
- CSR Projects approved by the Board for FY 2022-23
- Archival Policy
- Dividend Distribution Policy
- Code of conduct for Directors and Senior Management
- Materiality Policy for identification of Material Creditors and for Litigation
- Policy for determining Material Group Companies
- Policy for determining Material Subsidiary
- Policy on materiality and dealing with the Related Party Transactions
- Terms and Conditions of appointment of Independent Directors
- Familiarization Programme for Independent Directors
- CSR Policy
- Policy on Board Diversity
- Nomination and Remuneration Policy
- Code of Practices and Procedures for Fair Disclosure of UPSI
- Whistle Blower Policy
- CSR Projects approved by the Board for FY 2021-22
- Business Responsibility Policy
- Familiarisation Programme for Independent Directors for FY 2021-22
Financials
Quarterly Results
Results for the Quarter & Half year Ended September 30, 2024
- Analyst Concall Transcript – Q2 & H1 FY25
- Unaudited Financial Results – Q2 & H1 FY2025
- Press Release – Q2 & H1 FY2025
- Earnings Presentation – Q2 & H1 FY2025
Results for Quarter & Half Year Ended September 30, 2024
Results for the Quarter Ended June 30, 2024
- Unaudited Financial Results – Q1 FY2025
- Press Release Q1 FY2025
- Earnings Presentation - Q1 FY2025
- Analyst Concall Transcript - Q1 FY2025
Audio Recording of Earnings call for Q1 FY 2025
Results for the Quarter & Year Ended March 31, 2024
- Audited Financial Results - Q4 FY2024
- Press Release Q4 FY2024
- Earnings Presentation - Q4 FY2024
- Analyst Concall Transcript Q4 & FY2024
Earnings Call Audio Recording – Q4 & FY 2024
Results for Quarter & Nine Months Ended December 31, 2023
Results for Quarter & Half Year Ended September 30, 2023
- Press Release Q2 & H1 FY2024
- Earnings Presentation Q2 & H1 FY2024
- UnAudited Financial Results – Q2 & H1 FY2024
- Analyst Concall Transcript Q2 & H1 FY24
Earnings call for Q2 & H1 FY 2024
Results for Quarter Ended June 30, 2023
- Press Release Q1 FY2024
- Earnings Presentation Q1 FY2024
- UnAudited Financial Results – Q1 FY2024
- Analyst Concall Transcript Q1 FY24
Earnings Call Audio Recording – Q1 FY 2024
Results for Quarter & Year Ended March 31, 2023
- Press Release Q4 FY2023
- Earnings Presentation Q4 FY2023
- Audited Financial Results – Q4 FY2023
- Analyst Concall Transcript Q4 & FY 23
Earnings Call Audio Recording – Q4 & FY 23
Results for Quarter & Nine Months Ended December 31, 2022
- Press Release Q3 & 9M FY2023
- Earnings Presentation Q3 & 9M FY2023
- UnAudited Financial Results – Q3 & 9M FY2023
- Analyst Concall Transcript Q3 & 9M FY2023
Earnings Call Audio Recording – Q3 & 9M FY2023
Results for Quarter & Half Year Ended September 30, 2022
- Press Release Q2 & H1 FY2023
- Earnings Presentation Q2 & H1 FY2023
- UnAudited Financial Results – Q2 & H1 FY2023
- Analyst Concall Transcript Q2 & H1 FY2023
Earnings Call Audio Recording – Q2 FY23
Results for Quarter Ended June 30, 2022
- Press Release Q1 FY2023
- Earnings Presentation Q1 FY2023
- UnAudited Financial Results Q1 FY2023
- Analyst Concall Transcript Q1 FY2023
Audio Recording Conference Call - Q1 FY23
Results for Quarter & Year Ended March 31, 2022
- Press Relase Q4 FY2022
- Earnings Presentation Q4 FY2022
- Audited Financial Results Q4 FY2022
- Analyst Webcast Transcript Q4 FY2022
Earnings Call Video Recording - Q4FY22
Annual Reports
2023-24
2021-22
2022-23
Subsidiary Financials
2023-24
- Rainbow Children's Hospital Private Limited - RCHPL Financials 2023-24
- Rainbow Speciality Hospitals Private Limited - RSHPL Financial 2023-24
- Rainbow Women & Children's Hospital Private Limited - RWCHPL Financials 2023-24
- Rosewalk Healthcare Private Limited - RHPL Financials 2023-24
- Rainbow Fertility Private Limited - RFPL Financials 2023-24
- Rainbow C R O Private Limited - RCROPL Financials 2023-24
2022-23
- Rainbow Children's Hospital Private Limited - RCHPL Financials 2022-23
- Rainbow Speciality Hospitals Private Limited - RSHPL Financial 2022-23
- Rainbow Women & Children's Hospital Private Limited - RWCHPL Financials 2022-23
- Rosewalk Healthcare Private Limited - RHPL Financials 2022-23
- Rainbow Fertility Private Limited - RFPL Financials 2022-23
- Rainbow C R O Private Limited - RCROPL Financials 2022-23
2021-22
- Rainbow Children’s Hospital Private Limited - RCHPL Financials 2021-22
- Rainbow Speciality Hospitals Private Limited - RSHPL Financial 2021-22
- Rainbow Women & Children’s Hospital Private Limited - RWCHPL Financials 2021-22
- Rosewalk Healthcare Private Limited - RHPL Financials 2021-22
- Rainbow Fertility Private Limited - RFPL Financials 2021-22
- Rainbow C R O Private Limited - RCROPL Financials 2021-22
Stock Exchange Disclosures
Annual Secretarial Compliance Report
Certificate for Dematerialisation under Regulation 74(5) of SEBI Depository Participants Regulations
- Certificate under Regulation 74(5) - September 30, 2024
- Certificate under Regulation 74(5) - June 30, 2024
- Certificate under Regulation 74(5) - March 31, 2024
- Certificate under Regulation 74(5) - December 31, 2023
- Certificate under Regulation 74(5)- September 30, 2023
- Certificate under Regulation 74(5)- June 30, 2023
- Certificate under Regulation 74(5)- March 31, 2023
- Certificate under Regulation 74(5)- December 31, 2022
- Certificate under Regulation 74(5)- September 30, 2022
- Certificate under Regulation 74(5) - June 30, 2022
Closure of Trading Window
- Closure of Trading Window- Sept 30, 2024
- Closure of Trading window – June 30, 2024
- Closure of Trading window – March 31, 2024
- Closure of Trading Window – December 31, 2023
- Closure of Trading Window – September 30, 2023
- Closure of Trading Window- March 31, 2023
- Closure of Trading Window- December 31, 2022
- Closure of Trading Window– September 30, 2022
- Closure of Trading Window - June 30, 2022
- Closure of Trading Window - May 11, 2022
Compliance Certificate for Share Transfer Facility Under Regulation 7(3) of SEBI Listing Regulations
Compliance Certificate of Transfer/Sub division request(s) under Regulation 40(9) of SEBI Listing Regulations
Disclosure of Related Party Transactions under Regulation 23(9) of SEBI Listing Regulations
- Related Party Transactions for the Half Year ended September 30, 2024
- Related Party Transactions for the Half Year ended March 31, 2024
- Related Party Transactions for the Half Year ended September 30, 2023
- Related Party Transactions for the Half Year ended March 31, 2023
- Related Party Transactions for the Half Year ended September 30, 2022
- Disclosure under Regulation 23(9) - March 31, 2022
Disclosure under Regulation 30 of SEBI Listing Regulations and Miscellaneous Disclosures
- Disclosure under Regulation 30(5)
- Resignation of Group Chief Operating Officer – October 27, 2024
- Outcome of Board Meeting – October 27, 2024
- Notice from the Directorate of Medical & Rural Health Services, Chennai, Tamil Nadu, dated October 23, 2024
- Intimation of Allotment of Equity Shares - 22.08.2024
- Outcome of Board Meeting – August 13, 2024
- Summary of Proceedings of 26th Annual General Meeting of the Company
- Intimation of Allotment of Equity Shares - 17.07.2024
- Intimation of GST notice
- Outcome of Board Meeting – May 19, 2024
- Addition of 50 bed additional block - Hydernagar, Hyderabad, Telangana
- Commencement of a new 80 bed spoke hospital at Anna Nagar, Chennai, Tamil Nadu
- Commencement of a new 90 bed spoke hospital at Sarjapur, Bengaluru, Karnataka
- Outcome of Board Meeting – Appointment of Non - Executive Director – January 24, 2024
- Outcome of Board Meeting – January 24, 2024
- Commencement of a new 60 bed spoke hospital at Himayat Nagar, Hyderabad, Telangana
- Credit Rating Intimation– December 6, 2023
- Outcome of Board Meeting – Appointment of Independent Director - October 30, 2023
- Outcome of Board Meeting – October 30, 2023
- Stock Units granted – August 7, 2023
- Outcome of Board Meeting – August 7, 2023
- Update on purchase of land parcels located in Sector 44 & Sector 56 of Gurugram, Haryana
- Summary of Proceedings of 25th Annual General Meeting of the Company
- Outcome of Board Meeting – May 31, 2023
- Disclosure under Regulation 30(5)
- Purchase of Land Parcels - May 14, 2023
- Outcome of Board Meeting - May 14, 2023
- Outcome of Board Meeting - Appointment of Auditors - May 14, 2023
- Stock Units granted – May 14, 2023
- Intimation – Credit Rating – April 26, 2023
- Outcome of Board Meeting - April 15, 2023
- Outcome of Board Meeting - March 18, 2023
- Commencement of New Hospital Financial District
- Outcome of Board Meeting – February 9, 2023
- Outcome of Board Meeting – November 3, 2022
- Summary of Proceedings of 24th Annual General Meeting of the Company
- Commencement of new Hospital OMR Chennai Tamil Nadu
- Press Release with regard to opening of new Hospital at OMR Chennai Tamil Nadu
- Outcome of Board Meeting - August 08, 2022
- Outcome of Board Meeting - May 27, 2022
- Disclosure under Regulation 30(5)
- Resignation of Group Chief Operating Officer
- Information as per SEBI (SBEB) Regulations- FY 22
Initial Disclosure by Large Corporate
Monitoring Agency Report
- Monitoring Agency Report – September 30, 2024
- Monitoring Agency Report – June 30, 2024
- Monitoring Agency Report – March 31, 2024
- Monitoring Agency Report – December 31, 2023
- Monitoring Agency Report – September 30, 2023
- Monitoring Agency Report – June 30, 2023
- Monitoring Agency Report – March 31, 2023
- Monitoring Agency Report – December 31, 2022
- Monitoring Agency Report – September 30, 2022
- Monitoring Agency Report- June 30, 2022
Notice of Board Meeting
- Notice of Board Meeting – October 27, 2024
- Notice of Board Meeting- August 13, 2024
- Notice of Board Meeting – May 19, 2024
- Notice of Board Meeting - January 24, 2024
- Notice of Board Meeting- October 30, 2023
- Notice of Board Meeting- August 7, 2023
- Notice of Board Meeting- May 14, 2023
- Notice of Board Meeting- Feb 9, 2023
- Notice of Board Meeting- Nov 3, 2022
- Notice of Board Meeting - Aug 08, 2022
- Notice of Board Meeting - May 27, 2022
Reconciliation of Share Capital Audit Report
- Reconciliation of Share Capital Audit Report – September 30, 2024
- Reconciliation of Share Capital Audit Report - June 30, 2024
- Reconciliation of Share Capital Audit Report - March 31, 2024
- Reconciliation of Share Capital Audit Report - December 31, 2023
- Reconciliation of Share Capital Audit Report- September 30, 2023
- Reconciliation of Share Capital Audit Report- June 30, 2023
- Reconciliation of Share Capital Audit Report – March 31, 2023
- Reconciliation of Share Capital Audit Report- December 31, 2022
- Reconciliation of Share Capital Audit Report- September 30, 2022
- Reconciliation of Share Capital Audit Report - June 30, 2022
Report on Corporate Governance
- Corporate Governance Report – September 30, 2024
- Corporate Governance Report - June 30, 2024
- Corporate Governance Report – March 31, 2024
- Corporate Governance Report - December 31, 2023
- Corporate Governance Report- September 30, 2023
- Corporate Governance Report- June 30, 2023
- Corporate Governance Report - March 31, 2023
- Corporate Governance Report- December 31, 2022
- Corporate Governance Report – September 30, 2022
- Corporate Governance Report- June 30, 2022
Schedule of Analyst / Institutional Investor Meeting
- Intimation of Analyst/Institutional Investor Meet – November 18 &19, 2024
- Q2 & H1 FY 25 Concall
- Intimation of Analyst/Institutional Investor Meet –Sept 27, 2024
- Intimation of Analyst/Institutional Investor Meet – Sept 20, 23 & 24, 2024
- Institutional Investor Meet – Sept 9 to 13, 2024
- Q1 FY25 Concall Invite
- Intimation of Analyst/Institutional Investor Meet – June 18 & 19, 2024
- Intimation of Analyst/Institutional Investor Meet – June 7, 11 & 13, 2024
- Q4 FY24 Concall Invite
- Intimation of Analyst/Institutional Investor Meet – February 29, 2024 & March 5, 2024
- Intimation of Analyst/Institutional Investor Meet - February 15 & 19 2024
- Q3 & 9M FY24 Concall Invite
- Intimation of Analyst/Institutional Investor Meet - November 21, 2023
- Q2 & H1 FY 24 Concall Invite
- Intimation of Analysts Institutional Investors Meet –September 25 & 26, 2023
- Intimation of Analysts Institutional Investors Meet – August 23, 2023
- Q1 FY 24 Concall Invite
- Intimation of Analysts Institutional Investors Meet - June 19, 2023
- Intimation of Analysts Institutional Investors Meet - June 8 & 9, 2023
- Q4 FY 23 Concall Invite
- Intimation of Analysts Institutional Investors Meet - March 13 to 15, 2023
- Intimation of Analysts Institutional Investor Meet - March 3, 2023
- Intimation of Analysts Institutional Investors Meet - Feb 28 & Mar 2, 2023
- Q3 & 9M FY 23 Concall Invite
- Intimation of Analysts/Institutional Investors Meet- December 9, 2022
- Intimation of Analysts/Institutional Investors Meet- November 16 to 17, 2022
- Intimation of Analysts/Institutional Investors Meet- November 7, 2022
- Q2 & H1 FY 23 Concall Invite
- Intimation of Analysts and Investor Meet – September 28, 2022
- Intimation of Analysts and Investor Meet - September 20, 2022
- Intimation of Analysts and Investor Meet - September 7, 2022
- Institutional Investors Meet - August 12, 2022
- Q4 FY 22 Concall Invite
- Q1 FY 23 Concall Invite
Shareholding Pattern
- Shareholding pattern – September 30, 2024
- Shareholding Pattern - June 30, 2024
- Shareholding Pattern as on March 31, 2024
- Shareholding Pattern December 31, 2023
- Shareholding Pattern September 30, 2023
- Shareholding Pattern as on June 30, 2023
- Shareholding Pattern as on March 31, 2023
- Shareholding Pattern as on December 31, 2022
- Shareholding pattern as on September 30, 2022
- Shareholding pattern as on June 30, 2022
- Shareholding Pattern as on May 06, 2022
Statement of Deviations or Variations
- Statement of Deviations or Variations – September 30, 2024
- Statement of Deviations or Variations – June 30, 2024
- Statement of Deviations or Variations – March 31, 2024
- Statement of Deviations or Variations – December 31, 2023
- Statement of Deviations or Variations – September 30, 2023
- Statement of Deviations or Variations – June 30, 2023
- Statement of Deviations or Variations – March 31, 2023
- Statement of Deviations or Variations –December 31, 2022
- Statement of Deviations or Variations – September 30, 2022
- Statement of Deviations or Variations - June 30, 2022
Statement of Investor Grievances under Regulation 13(3) of SEBI Listing Regulations
- Certificate under Regulation 13(3) – September 30, 2024
- Certificate under Regulation 13(3) – June 30, 2024
- Certificate under Regulation 13(3) – March 31, 2024
- Certificate under Regulation 13(3) – December 31, 2023
- Certificate under Regulation 13(3) – September 30, 2023
- Certificate under Regulation 13(3) – June 30, 2023
- Certificate under Regulation 13(3) - March 31, 2023
- Certificate under Regulation 13(3)- December 31, 2022
- Certificate under Regulation 13(3)- September 30, 2022
- Certificate under Regulation 13(3) - June 30, 2022
Dividend
Dividend Communications
Credit Rating
Credit Rating
| Date of Credit Rating | Name of Credit Rating Provider | Rating Assigned | ICRA Credit Rating letter |
|---|---|---|---|
| December 6, 2023 | ICRA Limited |
Long Term Rating - [ICRA] AA (Stable)
{Upgraded from [ICRA] AA- (Positive)} |
View |
Listing on Stock Exchanges
Listing on Stock Exchanges
The Ordinary Shares of the Company are listed on the following 2 Stock Exchanges in India:
| Name Of Stock Exchange | Address | Stock Codes / Symbols |
|---|---|---|
| BSE Limited | Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. | 543524 |
| National Stock Exchange of India Limited | Exchange Plaza, Bandra-Kurla Complex, Bandra East, Mumbai 400 051 | RAINBOW |
Investor Contact
For Analysts & Institutional Investors
Mr. Vikas Maheshwari,Chief Financial Officer
Mr. Saurabh Bhandari,Group Business Analyst
- 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad – 500 034, Telangana
- +91 40 49692244
- investorrelations@rainbowhospitals.in
For Investor Grievances/Officer(s) for the IEPF Authority
Ashish Kapil, Nodal Officer, Company Secretary & Compliance Officer
- 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad – 500 034, Telangana
- +91 40 49692244
- companysecretary@rainbowhospitals.in
KFin Technologies Limited
M Murali Krishna
- Plot 31 and 32, Financial District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500 032, Telangana, India
- +91 40 6716 2222
- +91 40 49692244
- einward.ris@kfintech.com
